Abstract
ejd.2012.1913 Auteur(s) : Malgorzata Kolesnik, Harald Gollnick, Bernd Bonnekoh bernd.bonnekoh@medizin.uni-magdeburg.de Department for Dermatology and Venereology, Otto-von-Guericke-University, Leipziger Str. 44, 39120 Magdeburg, Germany Alitretinoin, as a dual RXR and RAR receptor agonist, is approved for the treatment of corticosteroid-refractory chronic hand eczema (CHE) [1]. There are several case reports in the literature that the drug may be of therapeutic benefit in other skin conditions also [...]
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
